Microbot Medical, Inc. Common Stock (MBOT) Stock Price

MBOTStock

$1.48−63.00%52W

Market Cap$99.40M

P/E—

PEG Ratio0.70

Div yield—

Beta1.01

MBOT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-53.66%

Price vs S&P 500 (4W)-17.93%

PEG Ratio0.70

VGM Score30.65

Book Value / Share (Quarterly)$1.10

P/TBV (Annual)11.71x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-6.10%

Cash Flow / Share (Quarterly)$-0.23

Price vs S&P 500 (YTD)-38.82%

Gross Margin (TTM)1.90%

Net Profit Margin (TTM)-3496.19%

EPS (TTM)$-0.28

10-Day Avg Trading Volume0.75M

EPS Excl Extra (TTM)$-0.28

Revenue Growth (5Y)0.40%

EPS (Annual)$-0.29

ROI (Annual)-16.95%

Gross Margin (Annual)82.79%

Net Profit Margin (5Y Avg)-5624.44%

Cash / Share (Quarterly)$1.08

Revenue Growth QoQ (YoY)-50.00%

ROA (Last FY)-16.12%

EBITD / Share (TTM)$-0.29

ROE (5Y Avg)-167.81%

Operating Margin (TTM)-4114.29%

Cash Flow / Share (Annual)$-0.20

P/B Ratio1.54x

P/B Ratio (Quarterly)2.18x

Net Income / Employee (Annual)$-305,600

EV / Revenue (TTM)1052.60x

Net Interest Coverage (TTM)-113.63x

ROA (TTM)-20.71%

EV / EBITDA (TTM)4.32x

EPS Incl Extra (Annual)$-0.29

Current Ratio (Annual)23.33x

Quick Ratio (Quarterly)21.73x

3-Month Avg Trading Volume1.10M

52-Week Price Return-63.00%

Revenue / Employee (TTM)$2,400

Tangible BV / Share (Quarterly)$97.43

P/S Ratio (Annual)113.05x

Asset Turnover (Annual)0.03x

52-Week High$4.67

Operating Margin (5Y Avg)-5730.35%

EPS Excl Extra (Annual)$-0.29

CapEx CAGR (5Y)-7.79%

Tangible BV CAGR (5Y)-27.14%

26-Week Price Return-41.73%

Quick Ratio (Annual)23.04x

13-Week Price Return-23.32%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)22.59x

Enterprise Value$110.52M

Revenue / Share Growth (5Y)-23.91%

Asset Turnover (TTM)0.00x

Book Value / Share Growth (5Y)-19.51%

Revenue / Employee (Annual)$23,500

Pretax Margin (Annual)-3194.06%

Cash / Share (Annual)$1.17

3-Month Return Std Dev56.11%

Net Income / Employee (TTM)$-330,500

ROE (Last FY)-16.95%

Net Interest Coverage (Annual)-113.00x

EPS Basic Excl Extra (Annual)$-0.29

P/FCF (TTM)4.76x

Receivables Turnover (TTM)27.71x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.28

Receivables Turnover (Annual)7.48x

ROI (TTM)-21.84%

P/S Ratio (TTM)1087.43x

Pretax Margin (5Y Avg)-5540.77%

Revenue / Share (Annual)$25.25

Tangible BV / Share (Annual)$137.75

Price vs S&P 500 (52W)-81.56%

Year-to-Date Return-26.00%

5-Day Price Return0.00%

EPS Normalized (Annual)$-0.29

ROA (5Y Avg)-108.07%

Net Profit Margin (Annual)-3241.58%

Month-to-Date Return-13.95%

Cash Flow / Share (TTM)$-1.14

EBITD / Share (Annual)$-0.31

Operating Margin (Annual)-3301.98%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-167.81%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.28

P/TBV (Quarterly)6.38x

P/B Ratio (Annual)1.73x

Pretax Margin (TTM)-3496.19%

Book Value / Share (Annual)$1.15

Price vs S&P 500 (13W)-25.27%

Beta1.01x

Revenue / Share (TTM)$0.00

ROE (TTM)-21.84%

52-Week Low$1.44

vGradeC

gGradeF

mGradeD

vgmGradeD

MBOT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.08	-$0.08	-4.34%(-$0.00)
Q1 2026	May 13, 2026	-$0.07	-$0.05	+28.57%(+$0.02)
Q4 2025	Mar 26, 2026	-$0.06	-$0.04	+33.33%(+$0.02)
Q3 2025	Nov 12, 2025	-$0.06	-$0.07	-16.67%(-$0.01)
Q2 2025	Aug 12, 2025	-$0.08	-$0.10	-25.00%(-$0.02)

MBOT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

4.13

4.11

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
MBOTMicrobot Medical, Inc. Common Stock	C	F	D	$1.48
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About Microbot Medical, Inc. Common Stock

Microbot Medical develops robotic solutions for endovascular procedures, a minimally invasive approach to treating vascular conditions. The company's LIBERTY Endovascular Robotic System is a single-use, remotely operated platform designed to enhance precision and provider safety in vascular interventions. With a robust intellectual property portfolio, Microbot aims to establish a new standard in endovascular care delivery.